Achieve Life Sciences, Inc. ( ACHV) - Key Metrics
ACHV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.80 | -$0.12 | -$0.12 |
| 2026Q1 | $0 | -$0.19 | -$0.13 | -$0.13 |
| 2025Q4 | $0 | -$0.28 | -$0.34 | -$0.34 |
| 2025Q3 | $0 | -$0.28 | -$0.22 | -$0.22 |
| 2025Q2 | $0 | -$0.37 | -$0.26 | -$0.26 |
ACHV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.04 |
| 2026Q1 | 0% | -3.87 |
| 2025Q4 | 0% | -4.44 |
| 2025Q3 | 0% | -2.81 |
| 2025Q2 | 0% | -1.53 |
ACHV
Price: $7.59
52 week price:
Earnings Per Share: -1.66 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 92500
Ebitda: -8.6 millionMarket Capitalization: 695.0 million